Morgan Stanley’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $36.6M | Sell |
2,498,825
-1,069,083
| -30% | -$17.1M | ﹤0.01% | 2413 |
|
|
2025
Q4 | $27.5M | Buy |
3,567,908
+2,950,684
| +478% | +$23.3M | ﹤0.01% | 2638 |
|
|
2025
Q3 | $4.55M | Sell |
617,224
-277,181
| -31% | -$1.42M | ﹤0.01% | 4237 |
|
|
2025
Q2 | $3.58M | Buy |
894,405
+220,881
| +33% | +$804K | ﹤0.01% | 4328 |
|
|
2025
Q1 | $2.14M | Buy |
673,524
+276,160
| +69% | +$1.3M | ﹤0.01% | 4564 |
|
|
2024
Q4 | $2.13M | Buy |
397,364
+4,102
| +1% | +$30.6K | ﹤0.01% | 4654 |
|
|
2024
Q3 | $2.08M | Buy |
393,262
+21,859
| +6% | +$78.5K | ﹤0.01% | 4622 |
|
|
2024
Q2 | $676K | Buy |
371,403
+96,042
| +35% | +$179K | ﹤0.01% | 5159 |
|
|
2024
Q1 | $490K | Sell |
275,361
-243,949
| -47% | -$509K | ﹤0.01% | 5316 |
|
|
2023
Q4 | $914K | Buy |
519,310
+326,804
| +170% | +$478K | ﹤0.01% | 5335 |
|
|
2023
Q3 | $281K | Buy |
192,506
+52,871
| +38% | +$112K | ﹤0.01% | 5432 |
|
|
2023
Q2 | $320K | Buy |
139,635
+39,476
| +39% | +$82K | ﹤0.01% | 5436 |
|
|
2023
Q1 | $91.1K | Buy |
100,159
+27,554
| +38% | +$21.5K | ﹤0.01% | 6045 |
|
|
2022
Q4 | $61.7K | Buy |
72,605
+33,288
| +85% | +$29.5K | ﹤0.01% | 6202 |
|
|
2022
Q3 | $32K | Sell |
39,317
-10,031
| -20% | -$9.57K | ﹤0.01% | 6594 |
|
|
2022
Q2 | $49K | Buy |
49,348
+8,486
| +21% | +$10.4K | ﹤0.01% | 6621 |
|
|
2022
Q1 | $67K | Buy |
40,862
+3,986
| +11% | +$7.3K | ﹤0.01% | 6547 |
|
|
2021
Q4 | $88K | Buy |
36,876
+6,933
| +23% | +$26.9K | ﹤0.01% | 6511 |
|
|
2021
Q3 | $145K | Sell |
29,943
-7,181
| -19% | -$21.3K | ﹤0.01% | 6168 |
|
|
2021
Q2 | $99K | Sell |
37,124
-129
| -0.3% | -$355 | ﹤0.01% | 6361 |
|
|
2021
Q1 | $115K | Sell |
37,253
-690
| -2% | -$2.49K | ﹤0.01% | 5933 |
|
|
2020
Q4 | $135K | Buy |
37,943
+5,197
| +16% | +$20.9K | ﹤0.01% | 5788 |
|
|
2020
Q3 | $131K | Buy |
32,746
+17,704
| +118% | +$70.7K | ﹤0.01% | 5300 |
|
|
2020
Q2 | $41K | Sell |
15,042
-17,878
| -54% | -$52.8K | ﹤0.01% | 5740 |
|
|
2020
Q1 | $69K | Sell |
32,920
-5,708
| -15% | -$23.2K | ﹤0.01% | 5339 |
|
|
2019
Q4 | $210K | Sell |
38,628
-6,744
| -15% | -$23.6K | ﹤0.01% | 5391 |
|
|
2019
Q3 | $136K | Buy |
45,372
+12,741
| +39% | +$53.5K | ﹤0.01% | 5327 |
|
|
2019
Q2 | $122K | Sell |
32,631
-24,668
| -43% | -$96.6K | ﹤0.01% | 5231 |
|
|
2019
Q1 | $230K | Buy |
57,299
+23,113
| +68% | +$97.6K | ﹤0.01% | 4984 |
|
|
2018
Q4 | $126K | Buy |
34,186
+10,394
| +44% | +$70.9K | ﹤0.01% | 5461 |
|
|
2018
Q3 | $204K | Sell |
23,792
-7,177
| -23% | -$71.8K | ﹤0.01% | 5449 |
|
|
2018
Q2 | $340K | Buy |
30,969
+6,621
| +27% | +$73.9K | ﹤0.01% | 5310 |
|
|
2018
Q1 | $281K | Buy |
24,348
+6,275
| +35% | +$59.3K | ﹤0.01% | 5318 |
|
|
2017
Q4 | $187K | Buy |
18,073
+3,937
| +28% | +$50.4K | ﹤0.01% | 5435 |
|
|
2017
Q3 | $226K | Buy |
14,136
+5,216
| +58% | +$72.2K | ﹤0.01% | 5295 |
|
|
2017
Q2 | $109K | Buy |
8,920
+4,205
| +89% | +$44.9K | ﹤0.01% | 5601 |
|
|
2017
Q1 | $98K | Sell |
4,715
-5,256
| -53% | -$82.3K | ﹤0.01% | 5606 |
|
|
2016
Q4 | $142K | Buy |
9,971
+9,063
| +998% | +$138K | ﹤0.01% | 5462 |
|
|
2016
Q3 | $15K | Buy |
+908
| New | +$13.1K | ﹤0.01% | 6002 |
|
|
2016
Q2 | – | Sell |
-219
| Closed | -$3K | – | 6533 |
|
|
2016
Q1 | $3K | Buy |
+219
| New | +$3.14K | ﹤0.01% | 6355 |
|
Other funds holding CRVS
O
ASP
VCM
VC
DTC
PA